These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

902 related articles for article (PubMed ID: 21297135)

  • 1. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer.
    Nakagiri T; Sawabata N; Funaki S; Inoue M; Kadota Y; Shintani Y; Okumura M
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):733-8. PubMed ID: 21297135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer.
    Prenzel KL; Mönig SP; Sinning JM; Baldus SE; Gutschow CA; Grass G; Schneider PM; Hölscher AH
    J Surg Oncol; 2003 Apr; 82(4):256-60. PubMed ID: 12672010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
    Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
    Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
    Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
    Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skip metastasis in nonsmall cell lung carcinoma: predictive markers and isolated tumor cells in N1 lymph nodes.
    Prenzel KL; Baldus SE; Mönig SP; Tack D; Sinning JM; Gutschow CA; Grass G; Schneider PM; Dienes HP; Hölscher AH
    Cancer; 2004 May; 100(9):1909-17. PubMed ID: 15112272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
    Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
    Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
    Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
    Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
    Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of stage pIIIA non small cell lung cancer after mediastinal lymph node dissection or sampling.
    Misthos P; Sepsas E; Kokotsakis J; Skottis I; Lioulias A
    J BUON; 2009; 14(1):45-9. PubMed ID: 19373946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. eComment: Stage IIIA-N2 non-small cell lung cancer: could a new scoring system improve the management of heterogeneous disease?
    Lococo F; Leuzzi G; Cafarotti S; Margaritora S
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):738. PubMed ID: 21555438
    [No Abstract]   [Full Text] [Related]  

  • 11. [Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases].
    Zhang GQ; Han F; Gao SL; A DL; Pang ZL
    Ai Zheng; 2007 May; 26(5):519-23. PubMed ID: 17672944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival.
    Lee JG; Lee CY; Park IK; Kim DJ; Park SY; Kim KD; Chung KY
    Ann Thorac Surg; 2008 Jan; 85(1):211-5. PubMed ID: 18154813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
    Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer.
    Misthos P; Sepsas E; Kokotsakis J; Skottis I; Lioulias A
    Ann Thorac Surg; 2008 Nov; 86(5):1626-30. PubMed ID: 19049761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors after complete resection of pN2 non-small cell lung cancer.
    Sonobe M; Date H; Wada H; Okubo K; Hamakawa H; Teramukai S; Matsumura A; Nakagawa T; Sumitomo S; Miyamoto Y; Okumura N; Takeo S; Kawakami K; Aoki M; Kosaka S;
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):788-95. PubMed ID: 23810113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2?
    Rea F; Marulli G; Callegaro D; Zuin A; Gobbi T; Loy M; Sartori F
    Lung Cancer; 2004 Aug; 45(2):215-20. PubMed ID: 15246193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic lymph node staging practice and stage-predicted survival after resection of lung cancer.
    Osarogiagbon RU; Allen JW; Farooq A; Berry A; O'Brien T
    Ann Thorac Surg; 2011 May; 91(5):1486-92. PubMed ID: 21524460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic evaluation of nodal staging based on the new IASLC lymph node map for lung cancer.
    Takamochi K; Oh S; Suzuki K
    Thorac Cardiovasc Surg; 2010 Sep; 58(6):345-9. PubMed ID: 20824587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer.
    Misthos P; Sepsas E; Athanassiadi K; Kakaris S; Skottis I
    Eur J Cardiothorac Surg; 2004 Apr; 25(4):502-8. PubMed ID: 15037262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.